Gastroenterology

Top Story

Direct-to-consumer genetic tests attempt to capture the zeitgeist of personalized medicine

January 28, 2020

In this Editorial, Jeff Balser, MD, PhD, President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, discusses the challenges of interpreting commercial genetic test results to patients and reviews tools that are being developed by researchers at Vanderbilt University Medical Center to help clinicians manage patients based on their genomic information.

FDA News

FDA approves Dificid for C. difficile treatment in children

January 27, 2020

The FDA has approved Dificid tablets and oral suspension for the treatment of Clostridioides difficile-associated diarrhea in pediatric patients aged older than 6…

Meeting News

Diet-as-therapy in IBD relies on shared decision-making, compliance

January 27, 2020

AUSTIN, Texas — Though clinical data for nutrition as therapy in IBD is limited, physicians should not be deterred from discussing it with patients if patients…

In the Journals

Individuals with alcohol use disorder have an increased fibrosis risk

January 27, 2020

The risk of fibrosis is highest in young adults with harmful drinking patterns and steatosis, according to data from a population-based study. “Approximately one…

Meeting News

Extraintestinal manifestations develop, worsen after Entyvio for IBD

January 25, 2020

AUSTIN, Texas — Approximately 30% of patients with inflammatory bowel disease developed new or worsening extraintestinal manifestations after receiving Entyvio…

More Headlines »

CME